
|
 |
Cardiovascular Research
Dr Alexander Galkin
Effect of conformational changes of
Complex I on mitochondrial hypoxic response, nitrosation of the
enzyme and postischaemic injury
Mitochondrial
complex I is located at an entry point of the electron transport
chain and catalyses electron transfer from NADH obtained in the
Krebs cycle to ubiquinone (coenzyme Q). Despite the importance of
complex I for cellular metabolism, little is known about its regulation
in vivo.
Complex I is known to undergo reversible conformational
changes in situations in which its turnover is limited. This unusual
behaviour of the enzyme is known as “active/de-active”
transition and has been observed in various membrane preparations
of the enzyme: mitochondria, submitochondrial particles or isolated
Complex I (for review see Vinogradov & Grivennikova, 2001).
In the absence of substrates and at physiological temperatures (>30ºC)
the mammalian enzyme is rapidly converted into the de-active, dormant
form. This form is catalytically incompetent but can be activated
by the slow reaction (k~4 min-1) of NADH oxidation with subsequent
ubiquinone reduction. After one or several turnovers the enzyme
becomes active and can catalyse physiological NADH:ubiquinone reactions
at a much higher rate (k~104 min-1).
Recently we found that these conformational
changes may have physiological significance. The de-active, but
not the active form of Complex I is susceptible to inhibition by
nitrosothiols and peroxynitrite, which most likely occurs at cysteine-39
of subunit ND3 (Fig 1) [Galkin et al, 2008; Galkin & Moncada,
2007]. It is likely that transition from the active to the de-active
form of complex I takes place during pathological conditions when
the turnover of the enzyme is limited at physiological temperatures,
such as during hypoxia, or when the tissue nitric oxide:oxygen ratio
increases (i.e. metabolic hypoxia [Moncada & Erusalimsky, 2002;
Galkin et al., 2007]). In such a situation the spontaneous de-activation
of complex I would result in increasing sensitivity to nitrosating
agents (S-nitrosoglutathione or peroxynitrite) followed by blocking
of the enzyme in the de-active state (Fig 2).
We propose that hypoxic A/D transition,
which is initially protective, may become an early step in the initiation
of pathophysiology during prolonged hypoxia or inflammation as a
result of the modification of Complex I via NO-dependent pathways,
which impedes its return to the A-form (Fig. 2).
Selected
publications
Galkin A, Meyer B, Wittig I, Karas M,
Schägger H, Vinogradov A, Brandt U. (2008). Identification
of the mitochondrial ND3 subunit as a structural component involved
in the active/deactive enzyme transition of respiratory complex
I. J.Biol.Chem. 283, 20907-20913. PMID: 18502755
Galkin A., Moncada S. (2007). S-nitrosation
of mitochondrial complex I depends on its structural conformation.
J.Biol.Chem. 282, 37448-37453. PMID: 17956863
Galkin A., Higgs A., Moncada S. (2007).
Nitric oxide and hypoxia. Essays Biochem. 43, 29-42. PMID: 17705791
Moncada S., Erusalimsky J.D. (2002).
Does nitric oxide modulate mitochondrial energy generation and apoptosis?
Nat.Rev.Mol.Cell.Biol. 3, 214-220. PMID: 11994742
Vinogradov, A.D., Grivennikova, V.G. (2001) The mitochondrial complex I: progress in understanding of catalytic properties. IUBMB Life, 52,129–134.
|
 |
Academic Career
2006-present Senior Research
Fellow, Wolfson Institute for Biomedical Research, UCL
2004 –2006 Postdoctoral
Fellow, University of Frankfurt, Germany Laboratory of Molecular
Bioenergetics
2001-2003 Postdoctoral Fellow
in Biochemistry Department of Lund University, Lund, Sweden.
1996- 2001 Ph.D. Biochemistry
Science, Department of Biochemistry School of Biology, Moscow State
University, Russia
Funding
TBA |
 |
Figure 1: Effect
of S-nitrosoglutathione on NADH-oxidase activity of the acitve (A)
and deactive (D) form of Complex I

Figure 2: De-activation
of Complex I in hypoxia results in exposure of cysteine-39 of the
ND3 subunit which can be modified by S-nitroso-glutathione or peroxynitrite.

Links
|